FDA Recalls Compounded Methylprednisolone Vials Linked to Skin Abscesses
Main Street Family Pharmacy is recalling compounded methylprednisolone vials after seven reports of skin abscesses.
The agency’s classification
FDA (Drugs): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 5/5 (Critical).
Highest-severity recall. The hazard can cause serious injury or death. Stop using the product now and follow the agency's instructions.
Our severity reasoning: The agency classification is FDA Class I, which mandates a severity score of 5 according to the rubric.
Plain-English summary
The U.S. Food and Drug Administration (FDA) has issued a Class I recall for compounded preservative-free methylprednisolone 80mg/ml 10ml vials manufactured by Main Street Family Pharmacy, LLC. The recall involves 1,312 units distributed nationwide to specific states including AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV. Affected lot numbers are 012813dan, 011413dan, and 010913dan.
The firm initiated the recall after receiving seven reports of adverse reactions in the form of skin abscesses potentially linked to the product. The FDA classifies this as a Class I recall, which is the most serious type of recall, indicating a reasonable probability that the use of or exposure to the violative product will cause serious adverse health consequences or death.
Consumers and healthcare providers should stop using the affected vials immediately and contact their healthcare provider for further instructions. The recalling firm is Main Street Family Pharmacy, LLC, located at 126 East Main Street, Newbern, TN 38059.
The recalled product
- Product
- Methylprednisolone 80mg/ml (PF) 10ml, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200
- Manufacturer
- Main Street Family Pharmacy, LLC
- Category
- Drug — Compounded Steroid
- Hazard
- Affected units
- 1,312
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot# 012813dan
- 011413dan
- 010913dan
Distribution
Part of a larger recall action
This product is one of 299 recalled by Main Street Family Pharmacy, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 299 products in this recall →Related recalls
Same manufacturer · Main Street Family Pharmacy, LLC
See all →- SevereMain Street Compounding Pharmacy Recalls Acetylcystein 10% Vials
FDA (Drugs) · 2013-12-11
- SevereMain Street Compounding Pharmacy Recalls Minoxidil 10% Due to Adverse Reactions
FDA (Drugs) · 2013-12-11
- SevereMain Street Compounding Pharmacy Recalls HCG 11000u w/B-12
FDA (Drugs) · 2013-12-11
- SevereMain Street Compounding Pharmacy Recalls Brompheniramine Due to Adverse Reactions
FDA (Drugs) · 2013-12-11
- SevereMain Street Compounding Pharmacy Recalls Methylcobalamin Due to Adverse Reaction Reports
FDA (Drugs) · 2013-12-11
Same hazard · skin abscess
See all →- SevereMain Street Compounding Pharmacy Recalls Lipotropic 10ml with B-12 and L-Carnitine
FDA (Drugs) · 2013-12-11
- SevereMain Street Compounding Pharmacy Recalls Testosterone Pellets Due to Adverse Reactions
FDA (Drugs) · 2013-12-11
- SevereMain Street Compounding Pharmacy Recalls Dexamethasone LA Due to Adverse Reactions
FDA (Drugs) · 2013-12-11
Similar recalls
- SevereUS Compounding Recalls Methylprednisolone Vials Due to Sterility Concerns
FDA (Drugs) · 2015-11-25
- CriticalFDA Recalls Methylprednisolone Acetate Injection Due to Non-Sterility
FDA (Drugs) · 2013-01-09
- SevereUS Compounding Recalls Methylprednisolone/Lidocaine Vials Due to Sterility Concerns
FDA (Drugs) · 2015-11-25
- SevereFDA Recalls Prostaglandin Tri-Mix Vials Due to Sterility Concerns
FDA (Drugs) · 2019-04-24
- SevereUS Compounding Recalls Betamethasone Vials Due to Sterility Concerns
FDA (Drugs) · 2015-11-25
- SevereGreen Valley Drugs Recalls Methylprednisolone Acetate Injection Due to Sterility Concerns
FDA (Drugs) · 2013-05-22